BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Health Education Advocacy Learning - ECPv6.16.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://healcollaborative.org
X-WR-CALDESC:Events for Health Education Advocacy Learning
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Kentucky/Louisville
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Kentucky/Louisville:20231007T120000
DTEND;TZID=America/Kentucky/Louisville:20231007T140000
DTSTAMP:20230927T235127Z
CREATED:20230821T163340Z
LAST-MODIFIED:20230927T235127Z
UID:1648-1696680000-1696687200@healcollaborative.org
SUMMARY:Kentucky Lung Cancer Program PT 2: Patient Navigation\, Targeted Treatment\, Public Policy\, and Clinical Trials
DESCRIPTION:This workshop will cover patient navigation\, clinical trials\, public policy\, and radiation therapy in the transition of lung cancer to a treatable disease. Health equity and improving access to multidisciplinary teams\, clinical trials\, and advanced treatments will be discussed. \nParticipants will also engage with their local elected officials to receive insight on how to partner together in order to influence change in healthcare. \n  \nLearning Objectives: \nTo identify the role of biomarker testing in transforming lung cancer into a treatable disease \nTo learn how to navigate through the healthcare system as a patient or caregiver \nTo understand why health inequities exist in cancer treatment and clinical trials \nTo describe the process of enrolling in clinical trials \nTo understand how clinical trials improve treatment outcomes and quality of life
URL:https://healcollaborative.org/event/if-you-have-lungs-you-can-get-lung-cancer-targeted-treatment-biomarker-testing-public-policy-and-clinical-trials/
LOCATION:St. Stephen Baptist Church\, 1018 South 15th Street\, Louisville\, KY\, 40210\, United States
ATTACH;FMTTYPE=image/png:https://healcollaborative.org/wp-content/uploads/2023/08/St-Stephen-1980x1080-Lung-Promo-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Kentucky/Louisville:20231014T100000
DTEND;TZID=America/Kentucky/Louisville:20231014T123000
DTSTAMP:20231005T180246Z
CREATED:20230927T233848Z
LAST-MODIFIED:20231005T180246Z
UID:1691-1697277600-1697286600@healcollaborative.org
SUMMARY:Atlanta- "I Will Remember You" A Community Conversation on Alzheimer’s  in Communities of Color
DESCRIPTION:HEAL Collaborative is partnering with Cornerstone Community Baptist Church in Atlanta\, GA\, to bring a two-part Alzheimer’s educational workshop series. Esteemed subject matter experts will share how Alzheimer’s impacts communities of color and how our participation in clinical trials matters. Caregivers will also join the discussion to provide first-hand accounts of their experiences caring for loved ones during their journey. Local advocacy organizations will share insights and information about their respective supportive resources. \nLunch will be provided. \nOCTOBER 14\, 2023 \n  \nWORKSHOP DETAILS: \nAlzheimer’s: Symptoms\, Early Diagnosis and Caregivers’ Panel \nAlzheimer’s disease (AD) is the most common form of dementia. More than 4 million Americans have AD. The disease is characterized by memory loss\, language deterioration\, poor judgment\, and an indifferent attitude. Dementia is a brain disorder that seriously affects a person’s ability to carry out daily activities. It involves the parts of the brain that control thought\, memory\, and language. Healthy brain tissue dies or deteriorates\, causing a steady decline in memory and mental abilities. \nThe goals of PART I of this education program are to help attendees: \n1) Understand Alzheimer’s and Dementia and recognize the signs and symptoms to promote early diagnosis \n2) Build a therapeutic alliance between physician and caregiver as an essential element in successfully managing their loved one living with AD \n3) Learn\, understand and apply techniques to reduce behavioral disturbances in a compassionate way\, promote independence\, activity and socialization to limit the need for pharmacological management \n4) Learn about available training programs and social support resources for caregivers. \n  \nThis event is being held both in-person and virtually. Please select how you plan to attend when registering. Lunch is being provided for all registered in-person attendees. \nThis event is in partnership with: \nHEAL Collaborative \n 
URL:https://healcollaborative.org/event/atlanta-i-will-remember-you-a-community-conversation-on-alzheimers-in-communities-of-color/
LOCATION:Cornerstone Community Baptist Church\, 4895 Campbellton Rd SW 30331\, Atlanta\, Georgia\, 30331
ATTACH;FMTTYPE=image/png:https://healcollaborative.org/wp-content/uploads/2023/09/FINAL-Eventbrite-CORNERSTONE-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Kentucky/Louisville:20231021T100000
DTEND;TZID=America/Kentucky/Louisville:20231028T123000
DTSTAMP:20230927T234441Z
CREATED:20230927T234441Z
LAST-MODIFIED:20230927T234441Z
UID:1695-1697882400-1698496200@healcollaborative.org
SUMMARY:Charlotte- “I Will Remember You” A Community Conversation on Alzheimer’s in Communities of Color
DESCRIPTION:HEAL Collaborative is partnering with Grier Heights Presbyterian Church in Charlotte\, NC\, to bring a two-part Alzheimer’s educational workshop series. Esteemed subject matter experts will share how Alzheimer’s impacts communities of color and how our participation in clinical trials matters. Caregivers will also join the discussion to provide first-hand accounts of their experiences caring for loved ones during their journey. Local advocacy organizations will share insights and information about their respective supportive resources. \n  \nOCTOBER 21: WORKSHOP PART I \nAlzheimer’s: Symptoms\, Early Diagnosis and Caregivers’ Panel \nAlzheimer’s disease (AD) is the most common form of dementia. More than 4 million Americans have AD. The disease is characterized by memory loss\, language deterioration\, poor judgment\, and an indifferent attitude. Dementia is a brain disorder that seriously affects a person’s ability to carry out daily activities. It involves the parts of the brain that control thought\, memory\, and language. Healthy brain tissue dies or deteriorates\, causing a steady decline in memory and mental abilities. \nThe goals of PART I of this education program are to help attendees: \n1) Understand Alzheimer’s and Dementia and recognize the signs and symptoms to promote early diagnosis \n2) Build a therapeutic alliance between physician and caregiver as an essential element in successfully managing their loved one living with AD \n3) Learn\, understand and apply techniques to reduce behavioral disturbances in a compassionate way\, promote independence\, activity and socialization to limit the need for pharmacological management \n4) Learn about available training programs and social support resources for caregivers. \n  \n  \nOCTOBER 28: WORKSHOP PART II \nAlzheimer’s: Diversity in Clinical Trials Participation & Policy   \nWithout clinical research and adequate representation\, there wouldn’t be sufficient information to provide African Americans with preventative measures\, treatment\, or a possible cure for Alzheimer’s Disease. \nWorkshop II will examine the role of clinical trials in advancing potentially promising treatment options for Alzheimer’s. We will also highlight the importance of including our children in conversations about their family member’s experiences with Alzheimer’s. Expert panelists will also explain the distinction between dementia and mental illness by sharing the symptoms and why seeking a professional diagnosis is vital. \nPART II WORKSHOP GOALS: To increase awareness of Alzheimer’s among African Americans and other communities of color to expand their participation in research and to get care\, services\, and treatments to those who are affected by the disease. Participants will learn the history and benefits of clinical trials. Healthcare professionals will discuss the process of enrolling in clinical trials and strategies to increase African-American recruitment and retention in clinical trials. \n  \nThis event is being held both in-person and virtually. Please select how you plan to attend when registering. Lunch is being provided for all registered in-person attendees. \n  \nThis event is in partnership with: \nHEAL Collaborative \nBiogen
URL:https://healcollaborative.org/event/charlotte-i-will-remember-you-a-community-conversation-on-alzheimers-in-communities-of-color/
LOCATION:Grier Heights Presbyterian Church\, 325 Skyland Avenue\, Charlotte\, North Carolina\, 28205
ATTACH;FMTTYPE=image/png:https://healcollaborative.org/wp-content/uploads/2023/09/FINAL-Eventbrite-Grier-Heights.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Kentucky/Louisville:20231028T100000
DTEND;TZID=America/Kentucky/Louisville:20231111T123000
DTSTAMP:20231017T222520Z
CREATED:20230927T234828Z
LAST-MODIFIED:20231017T222520Z
UID:1699-1698487200-1699705800@healcollaborative.org
SUMMARY:Dallas- “A Time to Remember” A Community Conversation on Alzheimer’s in Communities of Color
DESCRIPTION:HEAL Collaborative is partnering with HEAL Collaborative is partnering with The Pleasant Grove Ministerial Alliance in Dallas\, TX\, to bring a two-part Alzheimer’s educational workshop series. Esteemed subject matter experts will share how Alzheimer’s impacts communities of color and how our participation in clinical trials matters. Caregivers will also join the discussion to provide first-hand accounts of their experiences caring for loved ones during their journey. Local advocacy organizations will share insights and information about their respective supportive resources.in Dallas\, TX\, to bring a two-part Alzheimer’s educational workshop series. Esteemed subject matter experts will share how Alzheimer’s impacts communities of color and how our participation in clinical trials matters. Caregivers will also join the discussion to provide first-hand accounts of their experiences caring for loved ones during their journey. Local advocacy organizations will share insights and information about their respective supportive resources. \n  \nLunch will be provided. \n  \nOCTOBER 28 \nWORKSHOP PART I: \nAlzheimer’s: Symptoms\, Early Diagnosis and Caregivers’ Panel \nAlzheimer’s disease (AD) is the most common form of dementia. More than 4 million Americans have AD. The disease is characterized by memory loss\, language deterioration\, poor judgment\, and an indifferent attitude. Dementia is a brain disorder that seriously affects a person’s ability to carry out daily activities. It involves the parts of the brain that control thought\, memory\, and language. Healthy brain tissue dies or deteriorates\, causing a steady decline in memory and mental abilities. \nThe goals of PART I of this education program are to help attendees: \n1) Understand Alzheimer’s and Dementia and recognize the signs and symptoms to promote early diagnosis \n2) Build a therapeutic alliance between physician and caregiver as an essential element in successfully managing their loved one living with AD \n3) Learn\, understand\, and apply techniques to reduce behavioral disturbances in a compassionate way\, promote independence\, activity\, and socialization to limit the need for pharmacological management \n4) Learn about available training programs and social support resources for caregivers. \n  \n  \nNOVEMBER 11 \nWORKSHOP PART II \nAlzheimer’s: Diversity in Clinical Trials Participation & Policy \nWithout clinical research and adequate representation\, there wouldn’t be sufficient information to provide African Americans with preventative measures\, treatment\, or a possible cure for Alzheimer’s Disease. \nWorkshop II will examine the role of clinical trials in advancing potentially promising treatment options for Alzheimer’s. We will also highlight the importance of including our children in conversations about their family member’s experiences with Alzheimer’s. Expert panelists will also explain the distinction between dementia and mental illness by sharing the symptoms and why seeking a professional diagnosis is vital. \nPART II WORKSHOP GOALS: To increase awareness of Alzheimer’s among African Americans and other communities of color to expand their participation in research and to get care\, services\, and treatments to those affected by the disease. Participants will learn the history and benefits of clinical trials. Healthcare professionals will discuss the process of enrolling in clinical trials and strategies to increase African-American recruitment and retention in clinical trials. \n  \nThis event is being held both in-person and virtually. Please select how you plan to attend when registering. Lunch is being provided for all registered in-person attendees. \n  \nThis event is in partnership with: \nHEAL Collaborative \nBiogen
URL:https://healcollaborative.org/event/dallas-i-will-remember-you-a-community-conversation-on-alzheimers-in-communities-of-color/
LOCATION:New Millennium Bible Fellowship Church\, 9026 Elam Rd\, Dallas\, Texas\, 75217
ATTACH;FMTTYPE=image/png:https://healcollaborative.org/wp-content/uploads/2023/09/FINAL-Eventbrite-NEW-MILLENNIUM.png
END:VEVENT
END:VCALENDAR